Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry

Ann Oncol. 2021 May;32(5):678-679. doi: 10.1016/j.annonc.2021.01.067. Epub 2021 Feb 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Androgens / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • COVID-19*
  • Humans
  • Male
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms* / epidemiology
  • Registries
  • SARS-CoV-2

Substances

  • Androgen Antagonists
  • Androgens
  • Antineoplastic Agents, Hormonal